We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current MIRA market cap is 12.24M. The company's latest EPS is USD -0.8106 and P/E is -1.05.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 |
Operating Income | -1.34M | -970k | -3.16M |
Net Income | -1.34M | -1.27M | -3.59M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 |
Operating Income | -2.15M | -7.05M | -8.53M |
Net Income | -2.18M | -7.06M | -11.98M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 398k | 3.83M | 9.02M |
Total Liabilities | 2.19M | 2.63M | 903k |
Total Equity | -1.79M | 1.2M | 8.12M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 3.36M | 858k | 4.93M |
Total Liabilities | 1.09M | 1.45M | 558k |
Total Equity | 2.26M | -596k | 4.37M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Operating | -1.08M | -1.74M | -3.5M |
Investing | N/A | N/A | N/A |
Financing | 725k | 1.41M | 9.01M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Operating | -1.38M | -5.61M | -4.53M |
Investing | N/A | N/A | N/A |
Financing | 4.18M | 3.15M | 8.78M |
Market Cap | 12.24M |
Price to Earnings Ratio | -1.05 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 2.73 |
Price to Book Ratio | 2.87 |
Dividend Yield | - |
Shares Outstanding | 14.78M |
Average Volume (1 week) | 19.2k |
Average Volume (1 Month) | 46.64k |
52 Week Change | -88.17% |
52 Week High | 7.9799 |
52 Week Low | 0.76 |
Spread (Intraday) | 0.08 (8.43%) |
Company Name | MIRA Pharmaceuticals Inc |
Address |
900 west platt street tampa, florida 33606 |
Website | https://www.mirapharmaceuticals.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions